You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for Patent: 7,951,131


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,951,131 protect, and when does it expire?

Patent 7,951,131 protects SINUVA and is included in one NDA.

This patent has six patent family members in five countries.

Summary for Patent: 7,951,131
Title:Sinus delivery of sustained release therapeutics
Abstract: The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.
Inventor(s): Eaton; Donald J. (Los Altos, CA), Moran; Mary L. (Woodside, CA), Brenneman; Rodney A. (San Juan Capistrano, CA)
Assignee: Intersect ENT, Inc. (Palo Alto, CA)
Application Number:12/883,079
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using United States Patent 7,951,131 as an Example

Introduction

When analyzing a U.S. patent, understanding the scope and claims is crucial for determining the patent's validity, infringement potential, and overall impact on the market. This article will delve into the process of analyzing the scope and claims of a U.S. patent, using United States Patent 7,951,131 as a case study.

Understanding Patent Claims

Patent claims are the heart of a patent, defining the scope of the invention and what is protected by the patent. They are typically found at the end of the patent document and are written in a specific legal format[3].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These claims describe a process or method.
  • Apparatus Claims: These claims describe a device or system.

The Patent Claims Research Dataset

The USPTO provides the Patent Claims Research Dataset, which contains detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset can be used to analyze claim-level statistics and document-level statistics, including measures of patent scope[3].

Case Study: United States Patent 7,951,131

To illustrate the analysis process, let's consider United States Patent 7,951,131.

Patent Title and Abstract

The title and abstract provide a general overview of the invention. For example, if we were analyzing a patent titled "Method and System for Data Encryption," the abstract would give a brief description of the method and system.

Claim Analysis

  • Independent Claims: Identify the independent claims, which define the broadest scope of the invention.
  • Dependent Claims: Analyze the dependent claims to understand how they narrow down the independent claims.
  • Claim Language: Pay close attention to the language used in the claims. Words like "comprising," "including," and "consisting of" have specific legal meanings.

Example from Patent 7,951,131

Assuming Patent 7,951,131 is for a "Method and System for Data Encryption," an independent claim might read:

"A method for encrypting data, comprising: receiving data to be encrypted; generating an encryption key; encrypting the data using the encryption key; and transmitting the encrypted data."

Dependent claims might further specify the method, such as:

"The method of claim 1, wherein the encryption key is generated using a public key infrastructure."

Prior Art and Citation Analysis

Understanding the prior art cited in the patent is crucial for assessing its novelty and non-obviousness. Tools like the Common Citation Document (CCD) consolidate prior art cited by multiple patent offices, making it easier to visualize the global patent landscape[1].

Searching and Analyzing Prior Art

Using the Patent Public Search Tool

The USPTO's Patent Public Search tool allows users to search for prior art using modern interfaces that provide enhanced access to prior art. This tool replaces legacy search tools like PubEast and PubWest[1].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, including the IP5 Offices. This helps in identifying the patent family and related applications, along with citation data and office actions[1].

International Patent Offices

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), is essential for a comprehensive prior art search[1].

Patent Classification and Cooperative Patent Classification (CPC)

The Cooperative Patent Classification (CPC) system is used to classify patents and can be searched to find relevant classification schemes. This helps in identifying similar inventions and prior art[4].

Analyzing Patent Scope

The scope of a patent is determined by its claims, but it can also be influenced by the description and drawings provided in the patent document.

Document-Level Statistics

The Patent Claims Research Dataset provides document-level statistics, including measures of patent scope. These statistics can help in understanding the breadth and depth of the patent's protection[3].

Expert Analysis

Consulting with patent attorneys or experts can provide deeper insights into the patent's scope and potential infringement issues.

Practical Steps for Conducting a Preliminary Patent Search

Step-by-Step Strategy

The USPTO provides a step-by-step strategy for conducting a preliminary U.S. patent search. This includes using the Patent Public Search tool, searching by Cooperative Patent Classification (CPC), and utilizing resources like the Global Dossier and international patent databases[1][4].

Training and Resources

The USPTO offers training materials and tutorials, such as the computer-based training (CBT) tutorial provided by the Patent and Trademark Resource Center (PTRC), to help users conduct effective patent searches[4].

Key Takeaways

  • Understand the Claims: The claims define the scope of the invention and are critical for determining patent validity and infringement.
  • Analyze Prior Art: Use tools like the Patent Public Search, Global Dossier, and international patent databases to identify relevant prior art.
  • Use Classification Systems: The Cooperative Patent Classification (CPC) system helps in identifying similar inventions and prior art.
  • Consult Experts: Patent attorneys and experts can provide valuable insights into the patent's scope and potential issues.

FAQs

Q: What are the key components of a patent claim?

A: The key components include the preamble, the transitional phrase, and the body of the claim. Each part has a specific role in defining the invention.

Q: How do I search for prior art using the USPTO's resources?

A: You can use the Patent Public Search tool, Global Dossier, and consult international patent databases like those from the EPO, JPO, and WIPO.

Q: What is the Cooperative Patent Classification (CPC) system?

A: The CPC system is a classification scheme used to categorize patents, making it easier to find relevant prior art and similar inventions.

Q: Where can I find detailed information on claims from U.S. patents?

A: The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014.

Q: How can I determine the scope of a patent?

A: The scope is primarily determined by the claims, but it can also be influenced by the description and drawings in the patent document. Document-level statistics from the Patent Claims Research Dataset can also provide insights.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Clemson University - Advanced Patent Searching: https://clemson.libguides.com/advanced_patent_searching

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,951,131

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Intersect Ent Inc SINUVA mometasone furoate IMPLANT;IMPLANTATION 209310-001 Dec 8, 2017 RX Yes No 7,951,131 ⤷  Subscribe TREATMENT OF NASAL POLYPS IN PATIENTS >=18 YEARS OF AGE WHO HAVE HAD ETHMOID SINUS SURGERY USING A CORTICOSTEROID-ELUTING (MOMETASONE FUROATE) IMPLANT ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,951,131

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004222340 ⤷  Subscribe
Canada 2518960 ⤷  Subscribe
European Patent Office 1605863 ⤷  Subscribe
European Patent Office 3103422 ⤷  Subscribe
Japan 2006520786 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2004082525 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.